Inactive Instrument

Highlights AXCA HEALPAR

Equities

AXLA

US05454B2043

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

North American Morning Briefing : November Rally Pauses Ahead of This Week's PCE Report	Nov. 28	DJ
Investors Look Forward to Fed Minutes, Economic Data as Exchange-Traded Funds, Equity Futures Rise Marginally Pre-Bell	Nov. 20	MT
Axcella Health to Implement 1-for-25 Reverse Stock Split -- Shares Dive After-Hours	23-09-14	MT
Axcella Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-05-04	AQ
Axcella Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-30	AQ
Axcella Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Axcella Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-30	CI
Axcella Health : 10K HTML Q4 22	23-03-29	PU
Axcella Health Secures US FDA's Approval to Start Trial in Long COVID Fatigue	23-02-16	MT
Axcella Therapeutics Announces FDA IND Clearance for Supporting Regulatory Path to Registration of AXA1125	23-02-15	CI
Prospect of Further Federal Reserve Interest Rate Increases Pressuring Exchange-Traded Funds, Equity Futures	23-01-24	MT
Axcella Therapeutics Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue	23-01-23	CI
North American Morning Briefing : Stocks Seen -2-	22-12-19	DJ
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-01	AQ
Axcella Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01	CI
Earnings Flash (AXLA) AXCELLA THERAPEUTICS Posts Q3 Loss $-0.34, vs. Street Est of $-0.38	22-11-01	MT
Axcella Health Inc. Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis	22-09-29	CI
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AXCA HEALPAR

Equities

AXLA

US05454B2043

Highlights

Filters